122 related articles for article (PubMed ID: 12142606)
1. CD117 (KIT receptor) expression in Merkel cell carcinoma.
Su LD; Fullen DR; Lowe L; Uherova P; Schnitzer B; Valdez R
Am J Dermatopathol; 2002 Aug; 24(4):289-93. PubMed ID: 12142606
[TBL] [Abstract][Full Text] [Related]
2. c-kit expression in primary and metastatic merkel cell carcinoma.
Feinmesser M; Halpern M; Kaganovsky E; Brenner B; Fenig E; Hodak E; Sulkes J; Okon E
Am J Dermatopathol; 2004 Dec; 26(6):458-62. PubMed ID: 15618926
[TBL] [Abstract][Full Text] [Related]
3. CD117, CK20, TTF-1, and DNA topoisomerase II-alpha antigen expression in small cell tumors.
Yang DT; Holden JA; Florell SR
J Cutan Pathol; 2004 Mar; 31(3):254-61. PubMed ID: 14984578
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status.
Andea AA; Patel R; Ponnazhagan S; Kumar S; DeVilliers P; Jhala D; Eltoum IE; Siegal GP
Hum Pathol; 2010 Oct; 41(10):1405-12. PubMed ID: 20594584
[TBL] [Abstract][Full Text] [Related]
5. Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
Swick BL; Srikantha R; Messingham KN
J Cutan Pathol; 2013 Jul; 40(7):623-30. PubMed ID: 23621836
[TBL] [Abstract][Full Text] [Related]
6. Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma.
Brunner M; Thurnher D; Pammer J; Geleff S; Heiduschka G; Reinisch CM; Petzelbauer P; Erovic BM
Mod Pathol; 2008 Jul; 21(7):876-84. PubMed ID: 18408656
[TBL] [Abstract][Full Text] [Related]
7. KIT receptor (CD117) expression in Merkel cell carcinoma.
Strong S; Shalders K; Carr R; Snead DR
Br J Dermatol; 2004 Feb; 150(2):384-5. PubMed ID: 14996126
[No Abstract] [Full Text] [Related]
8. Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis.
Kartha RV; Sundram UN
Mod Pathol; 2008 Feb; 21(2):96-104. PubMed ID: 18084259
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.
Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA
J Cutan Pathol; 2007 Apr; 34(4):324-9. PubMed ID: 17381803
[TBL] [Abstract][Full Text] [Related]
10. Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma.
Waltari M; Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
Int J Cancer; 2011 Aug; 129(3):619-28. PubMed ID: 20949558
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.
Krasagakis K; Kruger-Krasagakis S; Eberle J; Tsatsakis A; Tosca AD; Stathopoulos EN
Dermatology; 2009; 218(1):37-43. PubMed ID: 19001805
[TBL] [Abstract][Full Text] [Related]
12. CD117 immunoreactivity in atypical fibroxanthoma.
Mathew RA; Schlauder SM; Calder KB; Morgan MB
Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
[TBL] [Abstract][Full Text] [Related]
13. Pure versus combined Merkel cell carcinomas: immunohistochemical evaluation of cellular proteins (p53, Bcl-2, and c-kit) reveals significant overexpression of p53 in combined tumors.
Lai JH; Fleming KE; Ly TY; Pasternak S; Godlewski M; Doucette S; Walsh NM
Hum Pathol; 2015 Sep; 46(9):1290-6. PubMed ID: 26099430
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase receptor RON and its ligand MSP in Merkel cell carcinoma.
Nagahama J; Daa T; Yada N; Kashima K; Fujiwara S; Saikawa T; Yokoyama S
Pathol Res Pract; 2011 Aug; 207(8):463-7. PubMed ID: 21723047
[TBL] [Abstract][Full Text] [Related]
15. SATB2 is expressed in Merkel cell carcinoma.
Fukuhara M; Agnarsdóttir M; Edqvist PH; Coter A; Ponten F
Arch Dermatol Res; 2016 Aug; 308(6):449-54. PubMed ID: 27262585
[TBL] [Abstract][Full Text] [Related]
16. Expression of HuR in Merkel cell carcinoma and in normal skin.
Koljonen V; Böhling T; Haglund C; Ristimäki A
J Cutan Pathol; 2008 Jan; 35(1):10-4. PubMed ID: 18095988
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma: lack of KIT positivity and implications for the use of imatinib mesylate.
Yang Q; Hornick JL; Granter SR; Wang LC
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):276-81. PubMed ID: 19276970
[TBL] [Abstract][Full Text] [Related]
18. CD56 staining in Merkel cell carcinoma and natural killer-cell lymphoma: magic bullet, diagnostic pitfall, or both?
McNiff JM; Cowper SE; Lazova R; Subtil A; Glusac EJ
J Cutan Pathol; 2005 Sep; 32(8):541-5. PubMed ID: 16115052
[TBL] [Abstract][Full Text] [Related]
19. Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.
Ames HM; Bichakjian CK; Liu GY; Oravecz-Wilson KI; Fullen DR; Verhaegen ME; Johnson TM; Dlugosz AA; Ross TS
J Invest Dermatol; 2011 Oct; 131(10):2113-20. PubMed ID: 21697888
[TBL] [Abstract][Full Text] [Related]
20. CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern.
Rajagopalan A; Browning D; Salama S
J Cutan Pathol; 2013 Jan; 40(1):19-24. PubMed ID: 23145531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
